A national sales director for a New York-based mobile diagnostic company has admitted in a Boston federal court to participating in a kickback scheme linked to unnecessary medical procedures. David Fuhrmann, 60, from Port Jefferson, New York, pleaded guilty to conspiracy to breach the Anti-Kickback Statute.
U.S. District Court Judge Nathaniel M. Gorton has set the sentencing date for July 10, 2025. The prosecution outlined that from June 2013 to September 2020, Fuhrmann collaborated with two managers of a mobile diagnostics company to create kickback arrangements with doctors.
The scheme involved offering kickbacks for ordering transcranial doppler (TCD) scans. Payments to doctors were made in both cash and checks, camouflaged as rental and administrative agreements. These contracts falsely suggested compensation was based on legitimate use of resources rather than the number of orders. The U.S. Attorney's office revealed that the scheme defrauded Medicare by approximately $70.6 million.
Under the Anti-Kickback Statute, Fuhrmann faces a maximum of five years in prison, three years of supervised release, and up to $250,000 in fines. Sentencing will be determined by federal guidelines.
The case is being handled by United States Attorney Leah B. Foley, with cooperation from several federal agencies. Assistant U.S. Attorneys Howard Locker and Mackenzie Queenin of the Health Care Fraud Unit lead the prosecution.
